Galera Therapeutics Inc
OTC:GRTX
Galera Therapeutics Inc
OTC:GRTX
Price:
0.0251
USD
18.4%
Market Cap:
$1.9m
Balance Sheet
Balance Sheet Decomposition
Galera Therapeutics Inc
Galera Therapeutics Inc
Balance Sheet Decomposition is not available for
Galera Therapeutics Inc
Galera Therapeutics Inc
Balance Sheet
Galera Therapeutics Inc
Galera Therapeutics Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
6
|
15
|
18
|
16
|
20
|
4
|
18
|
8
|
|
| Cash Equivalents |
6
|
15
|
18
|
16
|
20
|
4
|
18
|
8
|
|
| Short-Term Investments |
8
|
67
|
94
|
57
|
51
|
27
|
0
|
0
|
|
| Total Receivables |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Current Assets |
1
|
2
|
5
|
5
|
6
|
7
|
3
|
1
|
|
| Total Current Assets |
15
|
84
|
118
|
78
|
77
|
39
|
22
|
10
|
|
| PP&E Net |
0
|
1
|
2
|
2
|
1
|
1
|
1
|
0
|
|
| PP&E Gross |
0
|
1
|
2
|
2
|
1
|
1
|
1
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
2
|
2
|
0
|
0
|
|
| Intangible Assets |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
|
| Goodwill |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Other Long-Term Assets |
0
|
1
|
1
|
2
|
2
|
2
|
0
|
0
|
|
| Other Assets |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Total Assets |
19
N/A
|
88
+366%
|
123
+40%
|
84
-32%
|
83
-1%
|
44
-47%
|
26
-41%
|
10
-61%
|
|
| Liabilities | |||||||||
| Accounts Payable |
2
|
4
|
4
|
5
|
5
|
4
|
1
|
1
|
|
| Accrued Liabilities |
2
|
3
|
6
|
9
|
8
|
10
|
4
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
4
|
6
|
10
|
14
|
13
|
13
|
5
|
2
|
|
| Long-Term Debt |
0
|
20
|
43
|
63
|
128
|
140
|
151
|
151
|
|
| Deferred Income Tax |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
|
| Total Liabilities |
5
N/A
|
27
+463%
|
54
+99%
|
78
+45%
|
141
+81%
|
153
+8%
|
157
+3%
|
154
-2%
|
|
| Equity | |||||||||
| Common Stock |
90
|
166
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Retained Earnings |
76
|
105
|
161
|
236
|
316
|
378
|
437
|
456
|
|
| Additional Paid In Capital |
0
|
0
|
231
|
242
|
258
|
269
|
306
|
308
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
14
N/A
|
61
+336%
|
70
+14%
|
6
-91%
|
58
N/A
|
109
-88%
|
131
-20%
|
144
-10%
|
|
| Total Liabilities & Equity |
19
N/A
|
88
+366%
|
123
+40%
|
84
-32%
|
83
-1%
|
44
-47%
|
26
-41%
|
10
-61%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
24
|
24
|
25
|
25
|
27
|
29
|
54
|
75
|
|
Switch to:
Switch to:
See Also
Discover More
